Working together to find answers for skin (cutaneous) lupus sufferers...

With 1.5 million Americans and at least 5 million people worldwide* affected by lupus, there is a critical need for medical advancement. There is currently an unmet need for a safe, effective, and well-tolerated medication to treat study participants living with skin lupus. This website describes an opportunity for people living with skin lupus to take part in a clinical research study.

Right now researchers are inviting adults living with discoid lupus erythematosus (DLE) or subacute cutaneous lupus erythematosus (SCLE) to take part in one of two clinical research studies (also called clinical trials). Each of the studies is being conducted at research centers across North America, and will test the safety and effectiveness of an investigational medication for individuals with lupus.

* Source: The Lupus Foundation of America